Posts by ericg
Boston VC firm OpenView winds down, dissolves $570M seventh fund
Earlier this year, the VC firm told the Business Journal it expected to make just under 20 investments out of its seventh fund. Read More
Read MoreLongmeadow Shops sold for $30.4M
The 62-year-old commercial center of the affluent bedroom community in Western Massachusetts was sold last week to a national property owner with headquarters in Florida. Read More
Read MoreMass General Brigham appoints first chief integration officer
Dr. O’Neil A. Britton will be Mass General Brigham’s first chief integration officer, as the state’s largest health system continues to combine services and staff across its many facilities. Read More
Read MoreGary Glick raises another $101M for immuno-oncology startup Odyssey Therapeutics
It’s the third nine-figure round the Boston-based startup has raised in as many years. Read More
Read MoreBoston PE firm raises $115M for 2nd fund, documents show
Launched in 2019 by Nik Shah and Daniel Gedney, Cohere Capital closed its first $200 million fund in the spring of 2020. Read More
Read MoreBoston-based Leerink Partners opens Miami office
Leerink Partners, a Boston-based healthcare investment firm, is expanding to Miami, marking the company’s sixth location in the U.S. Read More
Read MoreFlagship spinout Axcella collapses, leaving future of its long Covid drug uncertain
A Flagship Pioneering-backed biotech behind one of the only new drugs in development for long Covid is closing its doors. Read More
Read MoreAuthors & Innovators gift ideas for thinkers: 2023 notable books
Larry Gennari, founder of the Authors & Innovators festival, has read some great books this year, and he’s recommending a dozen titles that should appeal to the most entrepreneurial minds on your holiday gift list. Read More
Read MoreJudge grants cannabis chair Shannon O’Brien’s motion to postpone hearing
Shannon O’Brien, who was suspended in September, argued that the closed-door meeting scheduled for Tuesday lacked procedural protections and would not have given her a fair hearing. Read More
Read MoreCVS launches plan to increase drug cost transparency
The price of the drug will be based on the amount CVS (NYSE: CVS) paid for the drug, plus a set markup and a flat fee to account for the pharmacist’s services. Read More
Read More